Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W V Daniels

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Microbiology|June 18, 2010
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapyGeraint B Rogers, Lucas R Hoffman, Marvin Whiteley, et al.
BMC Pulmonary Medicine|April 17, 2009
Studying bacteria in respiratory specimens by using conventional and molecular microbiological approachesGeraint B Rogers, Thomas W V Daniels, Andrew Tuck, et al.
Scientific Reports|November 27, 2021
Using explainable machine learning to characterise data drift and detect emergent health risks for emergency department admissions during COVID-19Christopher Duckworth, Francis P Chmiel, Dan K Burns, et al.
Microbiology Spectrum|July 31, 2025
Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infectionsMichelle Hardman, Sarah Higgi, Liam Hanson, et al.
Journal of Clinical Microbiology|September 27, 2013
Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesiaGeraint B Rogers, Mary P Carroll, Nur Masirah M Zain, et al.
The ISME Journal|November 12, 2015
Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial interventionLeah Cuthbertson, Geraint B Rogers, Alan W Walker, et al.
Thorax|June 19, 2012
Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilienceFranziska Anne Stressmann, Geraint B Rogers, Christopher J van der Gast, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 14, 2011
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?Franziska A Stressmann, Geraint B Rogers, Peter Marsh, et al.
Microbiome|May 30, 2026
Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapyHelen Gavillet, Lauren R Hatfield, Michelle Hardman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2023
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosisKevin W Southern, Carlo Castellani, Elise Lammertyn, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Microbiology|June 18, 2010
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapyGeraint B Rogers, Lucas R Hoffman, Marvin Whiteley, et al.
BMC Pulmonary Medicine|April 17, 2009
Studying bacteria in respiratory specimens by using conventional and molecular microbiological approachesGeraint B Rogers, Thomas W V Daniels, Andrew Tuck, et al.
Scientific Reports|November 27, 2021
Using explainable machine learning to characterise data drift and detect emergent health risks for emergency department admissions during COVID-19Christopher Duckworth, Francis P Chmiel, Dan K Burns, et al.
Microbiology Spectrum|July 31, 2025
Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infectionsMichelle Hardman, Sarah Higgi, Liam Hanson, et al.
Journal of Clinical Microbiology|September 27, 2013
Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesiaGeraint B Rogers, Mary P Carroll, Nur Masirah M Zain, et al.
The ISME Journal|November 12, 2015
Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial interventionLeah Cuthbertson, Geraint B Rogers, Alan W Walker, et al.
Thorax|June 19, 2012
Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilienceFranziska Anne Stressmann, Geraint B Rogers, Christopher J van der Gast, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 14, 2011
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?Franziska A Stressmann, Geraint B Rogers, Peter Marsh, et al.
Microbiome|May 30, 2026
Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapyHelen Gavillet, Lauren R Hatfield, Michelle Hardman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2023
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosisKevin W Southern, Carlo Castellani, Elise Lammertyn, et al.
Pageof 1